Study confirms the predictability of nonclinical models to humans, and show that preclinical data together with a carefully designed and monitored SAD study may provide reliable information for an early and science-based development decision.
Over 400 attendees from across the globe are participating in the SPS Annual meeting this week.
Tuesday opened with an ECG historical talk by Dr. Marc Vos, and the Introduction to Tracks talks by Dr. Jack Reynolds and Dr. Jean-Pierre Valentin (via WebEx!) Their talks covered both the Challenges for
Three interesting articles in the last NRDD issue: One on drug attrition, one on 2013 FDA approval, and one the CSRC-HESI-FDA workshop on QT.